Add BrightSurf on Google Email

YCU Advanced Medical Research Center


New PET imaging study reveals how ketamine relieves treatment-resistant depression

A new PET imaging study reveals that ketamine relieves treatment-resistant depression by altering AMPAR in brain regions, providing potential biomarker for personalized treatment. The study found that ketamine increased AMPAR density in several cortical regions and decreased it in reward-related areas, strongly correlating with reducti...

SourceYCU Advanced Medical Research Center·JournalMolecular Psychiatry·TypeImaging analysis·DateMar 6, 2026

Scanning synaptic receptors: A game-changer for understanding psychiatric disorders

Researchers developed a method to visualize AMPA receptors using PET scans, revealing differences in density and distribution between healthy subjects and those with psychiatric disorders. This discovery may lead to new diagnostic and therapeutic approaches for conditions like schizophrenia, bipolar disorder, and autism spectrum disorder.

SourceYCU Advanced Medical Research Center·JournalMolecular Psychiatry·TypeObservational study·DateNov 5, 2024

New study shows key role of synaptic plasticity in modulating brain function in patients with epilepsy

Researchers used a radiotracer to investigate AMPAR trafficking in patients with epilepsy, finding a positive correlation between cell surface AMPAR density and gamma activity. The study suggests that Hebbian and homeostatic plasticity differentially regulate brain function in epilepsy.

SourceYCU Advanced Medical Research Center·JournalCell Reports Medicine·TypeExperimental study·DateMay 16, 2023